BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 32353193)

  • 1. Is the type of diabetes treatment relevant to outcome of COVID-19?
    Bloomgarden Z
    J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M; Gazzerro P
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
    Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
    Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
    [No Abstract]   [Full Text] [Related]  

  • 4. Sofosbuvir for COVID-19 infection: A potential candidate.
    Gupta R; Dhamija P
    Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
    Ryan PM; Caplice N
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
    DiNicolantonio JJ; Barroso J; McCarty M
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32895293
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications.
    Russo V; Rago A; Carbone A; Bottino R; Ammendola E; Della Cioppa N; Galante D; Golino P; Nigro G
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):138-145. PubMed ID: 32453074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.
    Nauka PC; Oran E; Chekuri S
    Thromb Res; 2020 Aug; 192():27-28. PubMed ID: 32419710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19 treatment update: follow the scientific evidence.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
    Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
    Rani S; Grover S; Mehra A; Sahoo S
    Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronavirus disease 2019 infection and the cardiovascular system.
    Romeo F; Calcaterra G; Barilla F; Mehta JL
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports.
    Bauer ME; Chiware R; Pancaro C
    Anesth Analg; 2020 Jul; 131(1):e22-e24. PubMed ID: 32221171
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

  • 18. Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic.
    Qian K; Hu S
    MAbs; 2020; 12(1):e1782600. PubMed ID: 32546047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social media in the era of COVID-19.
    Aggarwal NR; Alasnag M; Mamas MA
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32994354
    [No Abstract]   [Full Text] [Related]  

  • 20. Do novel drugs for diabetes help in COVID-19? Another brick in the wall?
    Krejner-Bienias A; Grzela K; Grzela T
    J Diabetes; 2020 Sep; 12(9):703-704. PubMed ID: 32388906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.